Impact of Anti-Citrullinated Protein Antibodies on Progressive Systemic Bone Mineral Density Loss in Patients With Early Rheumatoid Arthritis After Two Years of Treat-to-Target
ObjectivesTo investigate the association of anti-citrullinated protein antibodies (ACPA) with changes in systemic bone mineral density (BMD) in patients with early rheumatoid arthritis (RA) after two years of treat-to-target.MethodsBMD was measured at the lumbar spine (LS) and femoral neck (FN) in 1...
Main Authors: | Serena Bugatti, Laura Bogliolo, Antonio Manzo, Ludovico De Stefano, Paolo Delvino, Francesca Motta, Carlomaurizio Montecucco |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.701922/full |
Similar Items
-
The Clinical Value of Autoantibodies in Rheumatoid Arthritis
by: Serena Bugatti, et al.
Published: (2018-12-01) -
B cell autoimmunity and bone damage in rheumatoid arthritis
by: S. Bugatti, et al.
Published: (2016-12-01) -
Novel autoantibodies in rheumatoid arthritis
by: A.F. Bonifacio, et al.
Published: (2019-04-01) -
Antibodies to citrullinated peptides are not associated with the rate of joint destruction in patients with a well-established diagnosis of rheumatoid arthritis
by: A.M. Nieto-Colonia, et al.
Published: (2008-03-01) -
Affinity Purification and Comparative Biosensor Analysis of Citrulline-Peptide-Specific Antibodies in Rheumatoid Arthritis
by: Eszter Szarka, et al.
Published: (2018-01-01)